The use of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with erosive hand osteoarthritis is safe and well tolerated and may potentially relieve pain, particularly in those with greater synovial inflammation, according to the sham-controlled ESTIVAL trial.